ArticleCancer cell international2025

Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer.

Nadia Bayou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.